Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin.

Clinical trial NCT00071071 · COMPLETED

Trial details

NCT number: NCT00071071
Sponsor: Genmab
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T-Cell Lymphoma

Start date: 2003-04-30
Primary completion: 2004-05-05
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.